Secondary Progressive Multiple Sclerosis
Is multiple sclerosis (MS) making everyday tasks harder for you?
Remaster is a clinical study for Secondary Progressive Multiple Sclerosis looking into an investigational study drug in a new class of disease-modifying therapies (DMTs).
This trial is for individuals between the ages of 18-65.
Study-related treatment, tests, and doctor visits are provided at no cost to you. Reimbursement for study-related expenses, such as meals, parking, or transportation may be available.
You may be able to join the REMASTER Study if you:
- Are 18 to 65 years of age
- Have a documented diagnosis of MS
- Have had no relapses within 2 years before starting the study
- Have some disability but are able to walk without assistance or with a walking aid such as a cane or crutch
- Do you have Secondary Progressive Multiple Sclerosis (SPMS)?
- Are you interested in a potentially disease-modifying therapy (study drug)?
We are happy to answer any questions you or your loved ones have and to see if you may be able to participate.